There was no significant difference in the incidence of severe hypoglycemia between participants with SGLT2i at baseline (5.9% vs 6.5%) and those without (2.2% vs 2.4%)
Reiss, A., Gulkarov, S., Lau, R., et al
With our Prescription Discount Card, available in-app, patients have saved from 7-20% on GLP-1 medications
This approach is designed for individuals who have significant weight to lose or who have struggled with weight management, and it often involves a combination of diet, exercise, behavior modification, and medications
They are fully licensed and accredited by the NABP (National Association of Boards of Pharmacy) and ACHC (Accreditation Commission for Health Care) across all 50 states and U.S
Physiology and pharmacology of effects of GLP-1-based therapies on gastric, biliary and intestinal motility